0 items USD 0.00Search
Your search for "globaldata chronic myelocytic leukemia cml chronic myeloid leukemia global clinical trials review h1" gave back 757545 results.
The global Bendamustine market size was valued at US$ 775.1 million in 2023. With growing demand in downstream market, the Bendamustine is forecast...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Idiopathic myelofibrosis is a chronic myelo-proliferative disorder and characterized by abnormal mutation of stem cells. This abnormal mutation of...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Hairy cell leukemia is a rare type of cancer of blood which is caused due to abnormal growth of B cells. The global Hairy cell Leukemia Treatment...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Hydroxyurea market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Midostaurin is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML),...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Mylotarg is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010. The...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Idhifa is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Acute lymphocytic/lymphoblastic leukemia (ALL) is a type of cancer that develops from immature lymphocytes. “Acute” here indicates leukemia that...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Homoharringtonine is an alkaloid obtained from the Tricuspidaceae plant, Tritaxus, or plants of the same genus. It has an inhibitory effect on the...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
